Breaking News Instant updates and real-time market news.

IDXG

Interpace Diagnostics

$1.01

-0.04 (-3.81%)

, LH

LabCorp

$170.58

-3.25 (-1.87%)

08:17
03/20/18
03/20
08:17
03/20/18
08:17

Interpace Diagnostics expands LabCorp national agreement

Interpace Diagnostics Group (IDXG) announced that the company has executed a new agreement with LabCorp (LH) to further expand the company's national network of cytology providers in support of its Thyroid molecular business unit. The arrangement builds on the parties' 2016 agreement, which established electronic ordering and result reporting through LabCorp for the Interpace's proprietary ThyGenX and ThyraMIR tests, which can provide physicians and patients with more specific diagnostic information about the presence of thyroid cancer in patients whose initial biopsy does not conclusively indicate whether a thyroid nodule is malignant or benign.Under the parties' new agreement, physicians will be able to order both thyroid biopsy analysis and molecular testing from Interpace. Dianon Pathology, a member of the LabCorp Specialty Testing Group, will be available to the biopsy analysis, and in the event of an indeterminate result, Interpace will then perform its molecular tests. In addition, physicians who order thyroid biopsy analysis services from Dianon can request an automatic reflex to Interpace's tests in the event of an indeterminate biopsy result, in which case Dianon will then automatically refer those samples to Interpace to perform the Company's proprietary assays, ThyGenX and ThyraMIR. Since Interpace first started offering integrated cytology services to customers, a significant percentage of cases ultimately deemed indeterminate have been referred to Interpace's molecular testing, providing physicians and patients with greater diagnostic clarity and reduced turnaround times, helping physicians and patients to more quickly learn whether there is a diagnosis of cancer, and allowing treatment to be commenced earlier when necessary.

IDXG

Interpace Diagnostics

$1.01

-0.04 (-3.81%)

LH

LabCorp

$170.58

-3.25 (-1.87%)

IDXG Interpace Diagnostics
$1.01

-0.04 (-3.81%)

03/08/18
03/08/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tyler Technologies (TYL) initiated with a Neutral at DA Davidson. 2. Interpace Diagnostics (IDXG) initiated with a Buy at H.C. Wainwright. 3. Crispr Therapeutics (CRSP) initiated with an Outperform at JMP Securities. 4. Quanta Capital Hldgs (QNTA) initiated with an Outperform at Northland. 5. Genocea (GNCA) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/08/18
HCWC
03/08/18
INITIATION
Target $3
HCWC
Buy
Interpace Diagnostics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Interpace Diagnostics with a Buy rating and $3 price target. The company's diagnostic offerings are differentiated in that PancraGEN has a positive predictive value significantly better than international guidelines for diagnosis of pancreatic malignancy, Selvaraju tells investors in a research note.
08/15/17
MAXM
08/15/17
INITIATION
Target $5
MAXM
Buy
Interpace Diagnostics initiated with a Buy at Maxim
Maxim analyst Jason Kolbert initiated Interpace Diagnostics with a Buy and a $5 price target saying its endocrine and pancreatic cancer diagnostic tests, ThyGenX and ThyraMIR, are growth drivers, and enable physicians to optimize the clinical course of action for patients with indeterminate cancer cytology. Kolbert said the endocrine cancer diagnostics are worth upwards of $350M.
LH LabCorp
$170.58

-3.25 (-1.87%)

03/19/18
ADAM
03/19/18
NO CHANGE
Target $115
ADAM
Buy
UnitedHealth contract a potential NT catalyst for Quest, says Canaccord
Canaccord analyst Mark Massaro raised his price target on Quest Diagnostics (DGX) to $115 from $113 following investor meetings with Shawn Bevec, Quest's Executive Director of IR. Massaro, who reiterated a Buy rating, views Quest as an underappreciated large cap "cash cow" well positioned to consolidate labs, particularly in the $48B hospital lab market, where he says it has a "competitive edge" over LabCorp (LH). Additionally, Massaro said the fate of the UnitedHealth (UNH) contract, an exclusive to LabCorp but is set to expire at the end of the year, remains a potential near-term positive catalyst for Quest, noting that Quest is in "active dialogue" with UnitedHealth executives at the highest levels" and at Optum. Though UnitedHealth could renew the deal with LabCorp, Massaro believes it is likely that the contract will open up to both LapCorp and Quest.
03/14/18
03/14/18
UPGRADE
Target $103

Equal Weight
Quest Diagnostics upgraded to Equal Weight at Morgan Stanley
As previously reported, Morgan Stanley analyst Ricky Goldwasser upgraded Quest Diagnostics (DGX) to Equal Weight from Underweight, noting that the stock's valuation has "drifted back" toward that of peer LabCorp (LH) and he now sees the risk/reward as balanced. While PAMA reimbursement cuts are a multiyear headwind to earnings, the impact appears to be reflected in Quest Diagnostics' share price, contends Goldwasser, who raised his price target on the stock to $103 from $95.
02/26/18
LEHM
02/26/18
NO CHANGE
Target $210
LEHM
Overweight
LabCorp price target raised to $210 from $195 at Barclays
Barclays analyst Jack Meehan raised his price target for Laboratory Corp. of America to $210 ahead of the company's analyst day. The analyst believes the company's "value proposition creates a compelling valuation case for the stock." He expects LabCorp to show proof points that its global life science strategy can deliver value to customers and shareholders. Meehan keeps an Overweight rating on the shares.
02/07/18
CHLM
02/07/18
NO CHANGE
Target $204
CHLM
Buy
LabCorp price target raised to $204 from $180 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich raised his price target for LabCorp to $204 from $180 following better than expected Q4 results. The analyst reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

MSFT

Microsoft

$103.68

0.7 (0.68%)

, AMD

AMD

$19.57

0.74 (3.93%)

14:36
12/18/18
12/18
14:36
12/18/18
14:36
Periodicals
Microsoft next Xbox console is codenamed Anaconda, Verge reports »

Microsoft's (MSFT)…

MSFT

Microsoft

$103.68

0.7 (0.68%)

AMD

AMD

$19.57

0.74 (3.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 03

    Mar

  • 04

    Mar

BIIB

Biogen

$293.41

-19.81 (-6.32%)

, RHHBY

Roche

$0.00

(0.00%)

14:32
12/18/18
12/18
14:32
12/18/18
14:32
Recommendations
Biogen drops after Bernstein sees potential downside of $100 on Q1 risks »

Bernstein analyst Aaron…

BIIB

Biogen

$293.41

-19.81 (-6.32%)

RHHBY

Roche

$0.00

(0.00%)

MYL

Mylan

$29.00

0.15 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 18

    Mar

DUK

Duke Energy

$87.77

-0.31 (-0.35%)

14:32
12/18/18
12/18
14:32
12/18/18
14:32
Hot Stocks
Former Duke Energy chairman and CEO Jim Rogers dies »

Jim Rogers, the former…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFMS

Conformis

$0.45

-0.0215 (-4.54%)

14:31
12/18/18
12/18
14:31
12/18/18
14:31
Hot Stocks
Conformis enters common stock purchase agreement with Lincoln Park Capital Fund »

Conformis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDC

First Data

$16.60

0.18 (1.10%)

14:30
12/18/18
12/18
14:30
12/18/18
14:30
Options
Hefty call spreads in First Data for the second time in three trading days »

Hefty call spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

BIIB

Biogen

$293.35

-19.87 (-6.34%)

, MYL

Mylan

$29.02

0.17 (0.59%)

14:29
12/18/18
12/18
14:29
12/18/18
14:29
Recommendations
Biogen, Mylan analyst commentary  »

Piper says Biogen…

BIIB

Biogen

$293.35

-19.87 (-6.34%)

MYL

Mylan

$29.02

0.17 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APEN

Apollo Endosurgery

$3.57

0.08 (2.29%)

14:27
12/18/18
12/18
14:27
12/18/18
14:27
Recommendations
Apollo Endosurgery analyst commentary  »

Craig-Hallum says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:20
12/18/18
12/18
14:20
12/18/18
14:20
General news
Canada CPI preview »

Canada CPI preview:…

TCEHY

Tencent

$0.00

(0.00%)

, DIS

Disney

$109.75

-0.88 (-0.80%)

14:18
12/18/18
12/18
14:18
12/18/18
14:18
Periodicals
'PUBG' on mobile has as many total users as 'Fortnite,' Verge reports »

The mobile version of…

TCEHY

Tencent

$0.00

(0.00%)

DIS

Disney

$109.75

-0.88 (-0.80%)

KKR

KKR

$19.89

0.09 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 11

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/18/18
12/18
14:17
12/18/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/18/18
12/18
14:16
12/18/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$6.72

-0.39 (-5.49%)

14:05
12/18/18
12/18
14:05
12/18/18
14:05
Options
McDermott call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$163.24

-0.19 (-0.12%)

14:02
12/18/18
12/18
14:02
12/18/18
14:02
Hot Stocks
General Dynamics unit awarded Department of Education contract »

General Dynamics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

APHA

Aphria

$5.87

0.43 (7.90%)

, TLRY

Tilray

$76.52

10.63 (16.13%)

14:00
12/18/18
12/18
14:00
12/18/18
14:00
Hot Stocks
Citron touts cannabis name Aphria again, sees shares above $8 by year-end »

Shares of Aphria (APHA)…

APHA

Aphria

$5.87

0.43 (7.90%)

TLRY

Tilray

$76.52

10.63 (16.13%)

ACB

Aurora Cannabis

$5.57

0.03 (0.54%)

MO

Altria Group

$51.40

-0.97 (-1.85%)

NVS

Novartis

$85.56

-0.24 (-0.28%)

CRON

Cronos Group

$11.50

0.375 (3.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 07

    Feb

STZ

Constellation Brands

$172.45

-3.61 (-2.05%)

13:55
12/18/18
12/18
13:55
12/18/18
13:55
Options
Constellation Brands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

MU

Micron

$34.81

0.92 (2.71%)

, UMC

UMC

$1.81

-0.005 (-0.28%)

13:50
12/18/18
12/18
13:50
12/18/18
13:50
On The Fly
Fly Intel: What to watch for in Micron's earnings report »

Micron (MU) is scheduled…

MU

Micron

$34.81

0.92 (2.71%)

UMC

UMC

$1.81

-0.005 (-0.28%)

INTC

Intel

$48.04

0.95 (2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 04

    Jan

  • 07

    Jan

  • 08

    Jan

VOD

Vodafone

$19.88

-0.13 (-0.65%)

13:48
12/18/18
12/18
13:48
12/18/18
13:48
Periodicals
Vodafone preparing to remove PwC as auditor, Sky News reports »

Vodafone is preparing to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,057.23

30.69 (2.99%)

, GOOG

Alphabet

$1,046.01

28.41 (2.79%)

13:40
12/18/18
12/18
13:40
12/18/18
13:40
Periodicals
Search engine startup claims Google still blocking competition, TechCrunch says »

The European Commission…

GOOGL

Alphabet Class A

$1,057.23

30.69 (2.99%)

GOOG

Alphabet

$1,046.01

28.41 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

KMX

CarMax

$60.38

0.11 (0.18%)

13:40
12/18/18
12/18
13:40
12/18/18
13:40
Options
7X average daily option volume in CarMax driven by an earnings hedge »

7X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

  • 31

    Jan

  • 01

    Feb

BIDU

Baidu

$169.94

0.03 (0.02%)

13:35
12/18/18
12/18
13:35
12/18/18
13:35
Hot Stocks
Unity Technologies, Baidu partner to develop autonomous vehicle simulation »

Unity Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$131.11

2 (1.55%)

13:32
12/18/18
12/18
13:32
12/18/18
13:32
Periodicals
J&J settles woman's talc cancer case for over $1.5M, Bloomberg reports »

Johnson & Johnson,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 27

    Jan

ORGS

Orgenesis

$4.84

-0.11 (-2.22%)

13:31
12/18/18
12/18
13:31
12/18/18
13:31
Hot Stocks
Orgenesis announces collaboration with MangoGen Pharma »

Orgenesis announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNN

Smith & Nephew

$36.67

-0.38 (-1.03%)

13:27
12/18/18
12/18
13:27
12/18/18
13:27
Hot Stocks
Smith & Nephew buys Ceterix Orthopaedics for $50M initial consideration »

Smith & Nephew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$81.62

1.12 (1.39%)

13:26
12/18/18
12/18
13:26
12/18/18
13:26
Hot Stocks
Albemarle higher after Hedgeye names new Best Idea Long »

Shares of Albemarle are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTWO

Take-Two

$104.09

1.87 (1.83%)

, ATVI

Activision Blizzard

$47.54

0.45 (0.96%)

13:24
12/18/18
12/18
13:24
12/18/18
13:24
On The Fly
Game On: Wedbush's Pachter says 'Red Dead 2' performing better than he expected »

SUCCESS OF 'RED DEAD 2':…

TTWO

Take-Two

$104.09

1.87 (1.83%)

ATVI

Activision Blizzard

$47.54

0.45 (0.96%)

EA

Electronic Arts

$81.22

2.01 (2.54%)

NTDOY

Nintendo

$0.00

(0.00%)

MSFT

Microsoft

$104.06

1.08 (1.05%)

SNE

Sony

$50.06

-0.425 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

  • 03

    Mar

  • 04

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.